SEC Form D filing

Cloverleaf Bio, Inc., 2026-09-09

An SEC Form D private-offering notice from New Haven, CT, a $29,599,977 filer-stated offering target in Biotech. Filed 2026-09-09. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Cloverleaf Bio, Inc. site↗ Verified via SEC Form D

RNA therapeutics company developing engineered tRNA based treatments for cancer, spun out of Yale University

Filed 2026-09-09Filed to raise $29,599,977First money in 2026-08-24Raised so far $14,799,988HQ (as filed) New Haven, CTSector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified cloverleafbio.com↗Named in the filing 5 executives & directors
Open this row on the live feed →More new filings in Connecticut →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source